[Alizapride in the treatment of vomiting induced by cytostatic agents].

Abstract

Most antineoplastic agents, particularly cisplatinum, cause nausea and vomiting. In an open study, 30 subjects receiving anticancer drugs were given the antiemetic Alizapride. The incidence of severe nausea was reduced from 50% to 24% on day 3. The percentage of patients without vomiting was raised to 77% until day 5. These results are in line with those of other clinical studies on Alizapride.

• Authors: H G Bierbaum
• Journal: Fortschritte der Medizin (Fortschr Med) Vol. 101 Issue 14 Pg. 662-4 (Apr 14 1983) ISSN: 0015-8178 [Print] Germany
• Vernacular Title: Alizaprid in der Behandlung des durch Zytostatika bedingten Erbrechens.
• PMID: 6852737 (Publication Type: English Abstract, Journal Article)

Chemical References

• Antiemetics
• Antineoplastic Agents
• Pyrrolidines
• alizapride

Topics

• Animals
• Antiemetics (therapeutic use)
• Antineoplastic Agents (adverse effects)
• Chemical Phenomena
• Chemistry
• Dogs
• Humans
• Male
• Pyrrolidines (therapeutic use)
• Vomiting (chemically induced, drug therapy)